Results 131 to 140 of about 24,922 (273)

Reduction in Post-Botulinum Toxin Flu-like Symptoms After Injection with Incobotulinum Toxin [PDF]

open access: yes, 2014
OBJECTIVE: To determine if patients reporting flu-like symptoms (FLS) after botulinum toxin (BoNT) injections are less susceptible to this reaction after incobotulinum toxin.
George, Edwin, Shneyder, Natalya
core   +1 more source

Video Urodynamic Study in Patients with Parkinson's Disease and Multiple System Atrophy

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 1, Page 173-180, January 2026.
Abstract Background Most studies have analyzed the urodynamic characteristics of patients with Parkinson's disease (PD) and multiple system atrophy (MSA) using conventional urodynamic studies. Objectives This study investigated the urodynamic characteristics of both diseases using video urodynamic study (VUDS).
Hyun Sik Yoon   +3 more
wiley   +1 more source

Producing positive control materials for template in PCR testing to detect botulinum neurotoxin types A and B genes

open access: yesTạp chí Kiểm nghiệm và An toàn thực phẩm
Botulinum neurotoxin (BoNT) is produced by the bacterium Clostridium botulinum and some other bacterial strains such as C. butyricum and C. baratii. It is considered the strongest toxin known to humans and can cause botulism.
Ninh Thi Hanh   +5 more
doaj   +1 more source

Amylase release from streptolysin O-permeabilized pancreatic acinar cells. Effects of Ca2+, guanosine 5'-[gamma-thio]triphosphate, cyclic AMP, tetanus toxin and botulinum A toxin [PDF]

open access: yes, 1992
The molecular requirements for amylase release and the intracellular effects of botulinum A toxin and tetanus toxin on amylase release were investigated using rat pancreatic acinar cells permeabilized with streptolysin O.
Ahnert-Hilger, G.   +4 more
core  

A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 1, Page 29-43, January 2026.
Abstract Background People with Parkinson's disease (PwP) face increased risks of complications and longer hospital stays compared to the general population. Four major factors contribute to increased morbidity and mortality during hospitalization: medication timing errors, administration of harmful medications, restricted mobility, and dysphagia ...
Ariane Veilleux Carpentier   +12 more
wiley   +1 more source

Paradoxical bulging of muscle after injection of botulinum neurotoxin type A into hypertrophied masseter muscle [PDF]

open access: bronze, 2012
Sang Ju Lee   +4 more
openalex   +1 more source

Reply to “Neurophysiological Testing to Diagnose Stiff‐Person Spectrum Disorder”

open access: yes
Movement Disorders Clinical Practice, Volume 13, Issue 1, Page 303-304, January 2026.
João Moura   +5 more
wiley   +1 more source

Efficacy and Safety of IncobotulinumtoxinA for Treatment of Sialorrhea: A Multicenter, Phase 3 Study in Japan

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 1, Page 120-130, January 2026.
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy